AI Summary
5 min readOn Wednesday, U.S. debt crossed $40 trillion for the first time, a milestone that economists say underscores an unsustainable fiscal trajectory, even if it doesn’t immediately hamstring the government. That story anchors a news roundup that also covers Moderna’s breakthrough cancer vaccine trial, a new FTC warning about personalized pricing, and a handful of other market and political developments.
U.S. Debt Hits $40 Trillion: Symbol of a Longer-Term Problem
The national debt has surpassed $40 trillion, a figure that WSJ markets reporter Matt Grossman described as a "huge and historic debt burden." On a day-to-day level, the milestone doesn’t prevent the Treasury from borrowing money to fund government salaries or Medicare payments. There remains a deep pool of investors willing to buy U.S. bonds, which keeps an "imminent fiscal crisis at bay." The concern is directional: the U.S. is not only carrying this much debt but is "still on the wrong course," adding more each year. Economists are increasingly forced to reckon with how the situation will resolve itself "in the years ahead and the decades ahead." Separately, the Treasury Department announced it would at least double its repurchases of longer-dated bonds, a move that sent the 30-year Treasury yield sliding after it hit its highest level in 19 years. The major stock indexes each gained about 0.2% on the day.
Continue reading the full summary in the app — free to try.
Read Full Summary →Free • No credit card required
Never miss an episode of WSJ What’s News
Get every new episode summarized in your inbox — free, ~5 minutes to read.
No spam. Unsubscribe anytime.
What you'll learn
- 1 A New Milestone for U.S. Debt: $40 Trillion
- 2 (00:26) **Moderna and Merck's Cancer Vaccine Breakthrough** - Moderna shares more than double after successful late-stage trial of an experimental personalized mRNA cancer vaccine for melanoma
- 3 (02:08) **FTC Targets Personalized Pricing by Retailers** - The Federal Trade Commission puts companies on notice for using consumer shopping data to tailor individual prices
- 4 (04:03) **Target's Strong Earnings and Turnaround** - Target reports second-quarter same-store sales rose 3.8% and raises full-year outlook
- 5 (05:00) **U.S. National Debt Surpasses $40 Trillion** - The debt milestone signals a broader concern about unsustainable fiscal trajectory
- 6 (06:40) **Treasury Bond Buybacks Send Yields Plunging** - Treasury Department announces it will at least double repurchases of longer-dated bonds
- 7 (07:13) **Israel Launches Criminal Investigations Into Gaza Attacks** - Military prosecutors will investigate two well-known attacks on Palestinians
+ Full timestamped outline available in the app
Guests on this episode
Show Notes
P.M. Edition for Aug. 19. Today the total U.S. debt passed $40 trillion. WSJ economics reporter Matt Grossman discusses what that means for how the government functions. Plus, a successful trial of a mRNA vaccine for melanoma could mean potential new treatments for a deadly cancer–and news of the trial results more than doubled Moderna’s stock price. And the Federal Trade Commission says retailers have to let shoppers know when they’re using their personal data to raise prices. Dave Michaels, who covers corporate law enforcement for the Journal, explains how personalized pricing works, and how the FTC is looking to rein it in. Alex Ossola hosts.
How Governments in the U.S. and Europe Are Stalling the AI Buildout
Sign up for the WSJ's free What's News newsletter.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
More from this podcast
WSJ What’s News →